Alphatec Holdings, Inc. (ATEC) is a publicly traded Healthcare sector company. As of May 21, 2026, ATEC trades at $8.35 with a market cap of $1.24B and a P/E ratio of -7.27. ATEC moved +0.12% today. Year to date, ATEC is -61.13%; over the trailing twelve months it is -36.47%. Its 52-week range spans $4.88 to $23.29. Analyst consensus is strong buy with an average price target of $18.91. Rallies surfaces ATEC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate ATEC?
11 analysts cover ATEC: 0 strong buy, 10 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $18.91.
Valentine Keith bought 35.00K (~$245.00K) on May 11, 2026.
Valentine Keith bought 43.85K (~$330.61K) on May 8, 2026.
Valentine Keith bought 56.15K (~$420.59K) on May 7, 2026.
Common questions about ATEC
What do analysts rate ATEC?
11 analysts cover ATEC: 0 strong buy, 10 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $18.91.
Does Rallies show ATEC price targets?
Yes. Rallies tracks ATEC analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ATEC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ATEC. It does not provide personalized investment advice.
